A new study published in Communications Medicine, a Nature publication, details the discovery of rare gene variants that increase the prevalence of Type 2 diabetes in multiple generations of Asian ...

Reports FY24 revenue $8.333M vs $15.451M last year. “We are pleased with the pace at which our TSHA-102 clinical program is advancing across a ...

High dose and low dose of TSHA-102 continue to be generally well tolerated with no treatment-related SAEs or DLTs in all pediatric, adolescent ...

AAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, ...

Apple shareholders on Tuesday are expected to reject an attempt to pressure the technology trendsetter into joining in the ...

Allen, along with Daryl "Chill" Mitchell and Belal "DJ Belal" Miller, started rapping as part of the 1980s New York group The ...

The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...

In a shift away from GMOS, aka genetically modified organisms, important research is continuing in gene editing, sometimes referred to as “the next big thing in agriculture.” The important ...

A new study links a particular gene to the ancient origins of spoken language, proposing that a protein variant found only in humans may have helped us communicate in a novel way. Speech allowed us to ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...

Regeneron Pharmaceuticals said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between ...